Li HF et al / Acta Pharmacol Sin 2004 Mar; 25 (3): 313-318
Phytoestrogen genistein decreases contractile response of aortic artery in vitro and arterial blood pressure in vivo
Hong-fang LI1, Long-de WANG2, Song-yi QU
Department of Physiology, Lanzhou Medical College, Lanzhou 730000;
2Affiliated Hospital, Gansu Chinese Medical College, Lanzhou 730020, China
1 Correspondence to Hong-fang LI. Phn 86-931-828-9146. Fax 86-931-867-8216. E-mail LHOF@163.net
Received 2003-04-16 Accepted 2003-09-24
KEY WORDS genistein; aorta; smooth muscle; muscle relaxation; calcium channel; vascular endothelium; blood pressure
ABSTRACT
AIM: To determine the mechanisms of effects of phytoestrogen genistein on the contracted rabbit aortic arteries in vitro, and observe the effect of genistein and 17-¦Â estradiol on mean arterial pressure (MAP) in ovariectomized (OVX) rats. METHODS: (1) Strips of rabbit aortic smooth muscle were suspended in organ baths containing Kreb's solution, and then isometric tension was measured. (2) Female mature Wistar rats underwent a bilateral ovariectomy (OVX). Sham-operated rats (SHAM) were used as controls. After administration of genistein (0.4 mg·kg-1·d-1, sc), 17-¦Â estradiol (1 mg·kg-1·d-1, sc) or their vehicle sesame oil for 21 d, MAP was measured. RESULTS: (1) Similar to 17-¦Â estradiol, genistein could dose-dependently relax 40 mmol/L KCl-precontracted arterial strips. Incubation with Nw-L-nitro-arginine (L-NNA), methylene blue (MB), indomethacin, propranolol or endothelium removal did not affect relaxation induced by genistein. In calcium-free solution containing 0.01mmol/L egtazic acid (EGTA), genistein inhibited not only the first phase contraction induced by noradrenaline (NA), but also the second contraction induced by CaCl2. In addition, genistein could reduce the contractile responses of NA, KCl and CaCl2, and shift their cumulative concentration-response curves rightward. (2) MAP in OVX rats was significantly higher compared with that of SHAM rats. However, after chronically treatment with genistein or 17-¦Â estradiol for 21 d the baseline MAP in OVX rats was reduced significantly. CONCLUSIONS: (1) The vasodilator effect of genistein in vitro is endothelium independent and not related to the nitric oxide, its mechanisms being probably due to inhibition of Ca2+ influx through calcium channels in a noncompetitive manner and Ca2+ release from intracellular store induced by NA. (2) Administration of genistein or 17-¦Â estradiol can chronically decrease MAP in OVX rats.
INTRODUCTION
Phytoestrogens are naturally found in many plants, particularly soy beans, and they are defined as plant substances that are structurally or functionally similar to estradiol[1,2]. Genistein, a phytoestrogen, may have estrogenic cardioprotective actions[3]. Epidemiological data suggest a reduction in the incidence of coronary heart disease in humans who have a high intake of phytoestrogens[4]. Increased plasma levels of the phytoestrogen genistein are suggested as an explanation for the infrequency of hot flashes and menopausal symptoms in women[5,6]. The affinity of genistein for the classic estrogen ¦Áreceptor presented on reproductive organ is less than that of estrogen[7]. However, genistein has a similar affinity as estrogen for the novel estrogen ¦Â receptor in the vasculture. Many studies demonstrate that in vitro 17-¦Âestradiol has a direct vasodilatory action which may partly contribute to its cardiovascular protection[8,9]. Recently there are evidences that phytoestrogen genistein also can be vasoactive, it enhances coronary vasoreactivity in macaque monkeys[10], relax mesenteric and coronary arteries in vitro[11,12], and also relax human forearm vasculature in vivo[13]. However the mechanism involved its vasodilator effect is not completely understood, and it is uncertain whether genistein can decrease blood pressure. Therefore, we assessed the relationship between vasorelaxation induced by genistein with Ca2+ influx, intracellular Ca2+ release, nitric oxide (NO), cyclic guanine monophosphate (cGMP), prostaglandins and adrenergic b receptors. We also investigated the effect of genistein and 17-¦Â estradiol on mean arterial pressure (MAP) in ovariectomized (OVX) rats.
MATERIALS AND METHODS
Drugs Genistein, 17-¦Â estradiol, Nw-L-nitro-arginine (L-NNA) (Sigma, Chemical Co, USA); acetylcholine (ACh) and propranolol ( The Second Pharmaceutical Factory of Beijing, China); indomethacin (Jiangsu Taicang Pharmaceutical Co, China); noradrenaline (NA, Datong Huida Pharmaceutical Factory, China); methylene blue (MB, Chemical Industry of Antichemical College, China). Genistein and 17-¦Â estradiol were dissolved in 1 % dimethylsulfoxide (Me2SO) in vitro experiment or in sesame oil in vivo experiment. Indomethacin was dissolved in a Na2CO3 solution at pH 7.4.
Arterial tension studies Adult male or nonpregnant female rabbits (general grade, certificate No 14-004) weighing 2.50±0.35 kg were purchased from Experimental Animal Center of Lanzhou Biological Productive Institute and all animal experiments were approved by the College Committee on the Use and Care of Animals. The rabbits were killed by stunning and exsanguinations. The thoracic aorta was rapidly removed and carefully cleaned of connective tissue and blood, then cut into spiral strip with 10 mm long and 3 mm wide. Each strip was suspended in a tissue chamber containing 37 ºC Krebs solution composed of (mmol/L) NaCl 120, KCl 5.9, NaH2PO4 1.2, MgCl2 1.2, NaHCO3 15.4, CaCl2 2.5, and glucose 11.5, bubbled with 95 % O2 and 5 % CO2. Isometric tension generated by vascular smooth muscle was measured using a force transducer (JH-2) and recorded with BL-410 Experimental System of Biological Function (TME, China) through IBM computer and 2D ink-writing recorders (Chengdu Instrument Plant). Resting tension was set to 2 g. After 90 min of equilibra-tion, the strips were activated with 1 µmol/L noradrenaline (NA) to check their contractility.
In some strips, the endothelium was removed by gentle rubbing with a cotton lot. In all tissues the presence or absence of a functionally intact endothelium was tested by measuring the ability of acetylcholine (1 µmol/L) to produce relaxation of tissues precontracted with NA (1 µmol/L).
After equilibration, various experiments were done.
(1) The strips were precontracted with 40 mmol/L KCl, when the contractile response had reached a stable plateau, genistein (1-500 µmol/L), 17-¦Â estradiol (1-500 µmol/L) or the same volume of solvent were added in progressively increasing cumulative concentrations every ten minutes.
(2) In some experiments, aortic strips with or without endothelium were treated with 40 mmol/L KCl. When the contractile response reached a plateau (approximately 15-20 min), genistein (250 µmol/L) or equivalent solvent was added. After 20 min, strips were washed with normal Krebs' solution, and then strips with endothelium were once again treated with KCl and the response to genistein was measured after preincubation with one of the following substances: 100 µmol/L Nw-L-nitro-arginine (L-NNA), 10 µmol/L methylene blue (MB), 10 µmol/L indomethacin, and 10 µmol/L propra-nolol.
(3) To evaluate the possible effect of genistein on NA-induced calcium release and calcium influx through receptor-operated calcium channels (ROCs), aortic strips denuded of endothelium were incubated in calcium-free solution containing 0.01 mmol/L egtazic acid (EGTA) for 30 min, and then treated with NA (1 µmol/L). When the contractile response had reached a plateau, CaCl2 (10 mmol/L) was added into the organ chamber and a further contraction was obtained. Tissues were washed with Ca2+-free solution and left to return to baseline tone. The strips were then treated with NA and CaCl2 again after being incubated with genistein (500 µmol/L) or the solvent.
(4) Strips were stabilized at 2 g resting tension for 90 min in Krebs' solution and the concentration-response curve to NA (0.03-10 µmol/L) was then obtained. After washout of NA, the experiment was repeated in the presence of genistein (100 or 500 µmol/L).
(5) The concentration-response curve to KCl (10-100 mmol/L) was observed in the absence or presence of genistein (50, 100 or 500 µmol/L).
(6) Aortic strips were incubated in calcium-free solution containing 0.01 mmol/L EGTA for 60 min. The calcium concentration-dependent contraction curve was then measured in K+ depolarization medium (40 mmol/L KCl). After washed with calcium-free solution, the strips were incubated with genistein (10 µmol/L) or equivalent solvent for 20 min and the calcium concentration-dependent contraction curve was then obtained again.
Arterial blood pressure measurement Female mature Wistar rats (grade II, certificate No 14-006) weighing 214.07±4.85 g underwent a bilateral ovariectomy (OVX). Sham-operated rats (SHAM) were used as control. One week after surgery, the OVX animals received daily subcutaneous injections of genistein (0.4 mg/kg), 17-¦Â estradiol (1 mg/kg) or injections of equivalent volume sesame oil at the same time. After 21 d, the rats were anesthetized with urethan (1 g/kg, ip). Polyethylene catheters were inserted into the external jugular vein for drug administration and into the common carotid artery for mean arterial pressure (MAP) measurement respectively. The arterial catheter was connected to a pressure transducer, and the blood pressure was displayed on the channel of BL-410 Experimental System of Biological Function (TME, China) through IBM computer. The changes of resting arterial blood pressure in different group rats was assessed.
Data analysis All results are expressed as mean±SD. Relaxation was expressed as percentage relaxation of contraction induced by KCl (40 mmol/L). In experiments involving a concentration-response curves, the results were expressed as percentage of control contractile response induced by 10 µmol/L NA, 100 mmol/L KCl and 10 mmol/L CaCl2 respectively. The EC50 values were calculated using a computer statistical package (SPSS 10.0 for Windows). Statistical analysis was performed using t-test and analysis of variance (ANOVA). Each group was compared with the solvent control. A probability level (P value) of less than 0.05 was considered significant.
RESULTS
Relaxing effects of genistein and 17-¦Â estradiol on KCl-precontracted aortic arteries In KCl precontracted endothelium-intact arterial strips, phytoestrogen genistein and 17-¦Â estradiol could dose-dependently induce a relaxation response (r=0.99, P<0.001) when compared to the solvent control (Fig 1).
Fig 1. Relaxant effects of genistein (GEN) and 17-¦Âestradiol (EST) on endothelium-intact rabbit aortic strips precontracted with 40 mmol/L KCl. n=8. Mean±SD. bP<0.05, cP<0.01 vs control.
Effects of L-NNA, MB, endothelium removal, indomethacin and propranolol on responses to genistein in KCl-treated strips Genistein (250 µmol/L) caused 27.76 %±2.66 % relaxation of KCl-treated strips (P<0.01, n=17). After incubation with L-NNA (100 µmol/L), MB (10 µmol/L), indomethacin (10 µmol/L), propranolol (10 µmol/L) or endothelium removal, percentages of relaxation induced by genistein (250 µmol/L) were 26.50 %±2.46 %, 28.77 %±4.68 %, 26.84 %±3.28 %, 33.71 %±5.41 %, and 30.22 %±4.34 %, respectively, and no obvious differences were found between them (all P>0.05, n=8).
Effects of genistein on biphasic contraction induced by NA and CaCl2 In calcium-free (0.01 mmol/L EGTA) Krebs' solution, NA (1 µmol/L) caused a transient contraction (1.02±0.32) g. As soon as such contraction reached a plateau, 10 mmol/L CaCl2 was rapidly added into the bath and another higher contractile response occurred (1.95±0.74 g, n=11). Genistein (250 µmol/L) reduced the first contraction induced by NA from 1.02±0.32 g to 0.38±0.18 g (P<0.01, n=11), and also reduced the second contraction caused by CaCl2 from 1.95±0.74 g to 1.60±0.84 g (P<0.05, n=11, Fig 2) in Ca2+-free solution.
Fig 2. Effects of genistein (GEN, 250 µmol/L) on contractile responses induced by NA and CaCl2.
Inhibitions of genistein on NA and KCl concentration-dependent contractile responses NA (0.03-10 µmol/L) and KCl (10-100 mmol/L) elicited concentration-dependent contractions in isolated aortic strips. However, genistein (50, 100, or 500 µmol/L) significantly reduced the responses to NA and KCl, and made their concentration-dependent contraction curves shifted to the right in a dose-dependent manner (Fig 3 and 4). The EC50 values in control and after treatment with genistein (100 or 500 µmol/L) were 1.51±0.30 µmol/L, 4.19±2.16 µmol/L (n=6, P<0.01 vs control) and 11.55±2.11 µmol/L (n=6, P<0.01 vs control) for NA respectively. The EC50 values in control and after treatment with genistein (50, 100, or 500 µmol/L) were (26.03±5.90) mmol/L, (38.80±8.70) mmol/L, (62.92±15.47) mmol/L (n=8, P<0.05 vs control) and (124.11±23.68) mmol/L (n=8, P<0.05 vs control) for KCl respectively.
Fig 3. Effects of genistein (GEN) (100 or 500 µmol/L) on NA-induced contraction of rabbit aorta. Data are expressed as percentage of maximal contraction induced by NA in controls. n=6. Mean±SD.
Fig 4. Effects of genistein (GEN) (50, 100, or 500 µmol/L) on KCl-induced contraction of rabbit aorta. Data are expressed as percentage of maximal contraction induced by KCl in controls. n=8. Mean±SD.
Inhibition of genistein on calcium concentration-dependent curve In K+(40 mmol/L) depolarized tissues in Ca2+-free medium, pretreatment with genistein (10 µmol/L) led to a reduction in the contractile response to CaCl2, shifting the concentration-response curve to the right (Fig 5). The EC50 values of calcium for control and 10 µmol/L genistein were (1.06±0.51) mmol/L and (6.09±1.93) mmol/L respectively (n=6, P<0.05 vs control).
Fig 5. Effect of genistein (GEN, 10 µmol/L) on calcium concentration-dependent contraction curve in rabbit aorta. Data are expressed as percentage of maximal contraction induced by calcium in controls. n=6. Mean±SD.
Effects of genistein and 17-¦Â estradiol on mean arterial pressure in OVX rats MAP in OVX rats was significantly higher compared with that of ovary-intact rats. However , after chronically treatment with genistein and 17-b estradiol for 21 d the baseline MAP in OVX rats (P<0.05, n=12) reduced significantly (Fig 6).
Fig 6. Effect of genistein (GEN, 0.4 mg·kg-1·d-1) and 17-¦Â estradiol (EST, 1 mg·kg-1·d-1) on mean arterial pressure (MAP) in OVX rats. MAP is shown in the following groups: Sham-operated rats (SHAM), ovariectomized (OVX), and OVX rats treated chronically with genistein (OVX+GEN) and 17-¦Â estradiol (OVX+EST) for 21 d. n=12. Mean±SD. bP<0.05 vs corresponding SHAM; eP<0.05 vs corresponding OVX.
DISCUSSION
We have shown that the phytoestrogen genistein induced significant relaxation of aortic artery strips in the similar way as 17-¦Â estradiol did. The relaxation was dose-dependent. The reports in effects of NO and endothelial cell on vasorelaxation induced by genistein are not consistent. In present experiment, no difference was observed between strips with or without endothelium. Preincubation with L-NNA, an inhibitor of NO synthesis, did not affect genistein-induced aortic artery relaxation. Methylene blue, an inhibitor of cGMP synthesis[14] and an important second messenger mediating vascular relaxation, also did not affect the relaxation induced by the phytoestrogen. Our results suggest that the relaxation of the rabbit aorta caused by genistein is independent on NO and on cGMP. Just as Marsh[15] reported that this is of therapeutic interest, as conceivably genistein might be used in patients with diseased and dysfunctional endothelium.
The endothelium might release vasoconstrictor and vasodilator prostaglandins. In our experiments, indomethacin did not affect the relaxation induced by genistein in the intact aorta. Propranolol, an antagonist of adrenergic b receptors, also did not affect vasorelaxation. These results indicate that the release of vasodilator prostanoids and adrenergic b receptors are not involved in aortic relaxation induced by genistein.
The vasoconstrictive responses to KCl are usually used to assess the contractile ability of the vascular smooth muscle[16]. Potential dependent calcium channels (PDCs) are activated by depolarization of the plasma membrane when the extracellular K+ concentration is increased. In our experiment, genistein relaxed KCl-precontracted aortic strips, and incubation with genistein not only shifted the KCl concentration-dependent contraction curves to the right in normal Krebs' solution but also moved the calcium concentration-dependent contraction curves to the right in high K+ depolarization medium, and inhibited KCl concentration-dependent contractile responses in a noncompetitive manner. These results are consistent with the effect of 17-¦Â estradiol on vessels as we reported previously[9] and supported by the other study[12]. In present study, our results suggest that genistein may have Ca2+ antagonistic properties and can inhibit extracellular Ca2+ influx through PDC.
Noradrenaline (NA) can activate receptor-operated calcium channels (ROCs) in the cellular membrane of vascular smooth muscle and increase calcium influx, while also activating G proteins and phospholipase C to produce inositol trisphosphate (IP3) which causes calcium release from endoplasmic reticulum[17]. In present experiment, genistein could decrease the concentration-dependent responses induced by NA, suggesting that genistein probably can inhibit Ca2+ influx via ROCs or Ca2+ release induced by IP3, but which one of them involved in the inhibition of contraction caused by NA is not completely understood. As we know, the contractile response to a number of agonists including NA comprises two distinct components in Ca2+-free medium: an initial phasic component that results from IP3-mediated release of Ca2+ from intracellular Ca2+ stores followed by a tonic component that requires addition of Ca2+ in the continuous presence of the agonist, due to Ca2+ influx[18]. This is so-called biphasic contraction induced by NA and Ca2+. We found that genistein not only attenuated NA-induced contraction but also decreased latter CaCl2-induced contraction significantly. These results indicate that the inhibitions of Ca2+ release and calcium influx induced by NA are all involved in the mechanisms of vascular smooth muscle relaxation caused by genistein.
The experiment in vivo showed that in OVX rats, compared with sham-operated animal, mean artery blood pressure (MAP) significantly increased, 17-¦Â estradiol significantly reverted the baseline MAP. This result is the same as a previous study[19]. However, the major finding of the present study is that treatment with phytoestrogen genistein can also decrease MAP in OVX rats, which probably give a reasonable explanation for Washburn's study[20] that soy supplementation in the diet of nonhypercholesterolemic, nonhypertensive and perimenopausal women resulted in significant decline in diastolic blood pressure.
In conclusion, phytoestrogen genistein can decrease contractile response of rabbit aortic artery in vitro and arterial blood pressure of OVX rats in vivo in the same way as 17-¦Â estradiol. The relaxation in vitro is endothelium-independent, and not related to NO, cGMP, the release of vasodilator prostanoids and adrenergic b receptor. The mechanism probably involves in the inhibitions of Ca2+ influx through calcium channels in a noncompetitive manner and Ca2+ release from intracellular stores induced by NA. Therefore, genistein has a similar vasoactivity as 17-¦Â estradiol does, and has a potential to replace estradiol in the prevention and treatment of vascular diseases.